Congenital melanocytic nevi evaluation and management

Dermatologic Clinics

Volumn 20, Issue 4, 2002, Pages 607-616

  Marghoob, Ashfaq A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

DNA CONTENT; DNA MICROARRAY; GENE AMPLIFICATION; HUMAN; INNERVATION; MELANOCYTIC NEVUS; MELANOMA; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DERMATOLOGY; EVALUATION STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEVUS, PIGMENTED; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036787379     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00030-X     Document Type: Review

References (72)

1. Rhodes AR. Benign neoplasias and hyperplasias of melanocytes. In: Freedberg IM, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill; 1999. p. 1018-59.
2. Mizushima J, Nogita T, Higaki Y, et al. Melanocytes in the dermis: do dermal melanocytes of acquired dermal melanocytosis exist from birth? Br J Dermatol 1998; 139:349-50.
3. Kopf AW, Levine LJ, Rigel DS, et al. Congenitalnevus-like nevi, nevi spili, and caf6-au-lait spots in patients with malignant melanoma. J Dermatol Surg Oncol 1985;11:275-80.
4. Cribier BJ, Santinelli F, Grosshans E. Lack of clinicalpathological correlation in the diagnosis of congenital naevi. Br J Dermatol 1999;141:1004-9.
5. Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol 1976;95:389-96.
6. Lorenz S, Maier C, Segerer H, et al. Skin changes in newborn infants in the first 5 days of life. Hautarzt 2000;51:396-400.
7. Rivers JK, MacLennan R, Kelly JW, et al. The Eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol 1995;32: 957-63.
8. Fung WK, Lo KK. Prevalence of skin disease among school children and adolescents in a Student Health Service Center in Hong Kong. Pediatr Dermatol 2000; 17:440-6.
9. Kopf AW, Levine LJ, Rigel DS, et al. Prevalence of congenital-nevus-like nevi, nevi spili, and café-au-lait spots. Arch Dermatol 1985;121:766-9.
10. Sigg C, Pelloni F, Schnyder UW. Frequency of congenital nevi, nevi spili and café-au-lait spots and their relation to nevus count and skin complexion in 939 children. Dermatologica 1990;180:118-23.
11. Rhodes AR, Albert LS, Weinstock MA. Congenital nevomelanocytic nevi: proportionate area expansion during infancy and early childhood. J Am Acad Dermatol 1996;34:51-62.
12. Dawson HA, Atherton DJ, Mayou B. A prospective study of congenital melanocytic naevi: progress report and evaluation after 6 years. Br J Dermatol 1996;134: 617-23.
13. Tokura Y, Yamanaka K, Wakita H,et al. Halo congenital nevus undergoing spontaneous regression: involvement of T-cell immunity in the involution and presence of circulating anti-nevus cell IgM antibodies. Arch Dermatol 1994;130:1036-41.
14. DeDavid M, Orlow SJ, Provost N, et al. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 1996;35:529-38.
15. Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital melanocytic nevi and the risk for the development of malignant melanoma: a prospective study. Arch Dermatol 1996;132:170-5.
16. Marghoob A, Kopf A, Bittencourt F. Moles present at birth: their medical significance. Skin Cancer Foundation Journal 1999;17:36-98.
17. Takayama H, Nagashima Y, Hara M, et al. Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis. J Am Acad Dermatol 2001;44:538-40.
18. Cramer SF. The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations. Pediatr Pathol Lab Med 1988;8:253-65.
19. Kos L, Aronzon A, Takayama H, et al. Hepatocyte growth factor/scatter factor-Met signaling in neural crest-derived melanocyte development. Pigment Cell Res 1999;12:13-21.
20. Takayama H, LaRochelle WJ, Anver M, et al. Scatter factor, hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A 1996;93:5866-71.
21. Otsuka T, Takayama H, Sharp R, et al. C-met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 1998;58:5157-67.
22. Natali PG, Nicotra MR, DiRenzo MF, et al. Expression of the c-met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 1993;68: 746-50.
23. Marghoob A, Bittencourt F, Kopf A, Bart R. Large congenital melanocytic nevi. Curr Probl Dermatol 2000; 146-52.
24. DeDavid M, Orlow SJ, Provost N, et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997;36:409-16.
25. Koot HM, DeWaard-van der Spek F, Peer CD, et al. Psychosocial sequelae in 29 children with giant congenital melanocytic naevi. Clin Exp Dermatol 2000;25: 589-93.
26. Ceballos P, Ruiz-Maldonado R, Mihm M. Melanoma in children. N Engl J Med 1995;332:656-62.
27. Kanzler MH, Marz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001;45:260-76.
28. Barnhill RL, Fleischli M. Histologic features of congenital melanocytic nevi in infants I year of age or younger. J Am Acad Dermatol 1995;33:780-5.
29. Marghoob AA, Schoenbach SP, Kopf AW, et al. Large congenital melanocytic nevi and the risk of developing malignant melanoma: a prospective study and review of the world literature. J Invest Dermatol 1995;104:563.
30. Rhodes AR, Wood WC, Sober AJ, et al. Nonepidermal origin of malignant melanoma associated with giant congenital nevocellular nevus. Plast Reconstr Surg 1981;67:782-90.
31. Mancianti M, Clark WH, Hayes FN, et al. Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. Am J Pathol 1990;136:817-29.
32. Leech S, Bell H, Lewis-Jones S, et al. Giant congenital pigmented naevi with proliferating nodules occurring in two neonates. Br J Dermatol 1999;141:32-3.
33. Kovach R, Hochberg J, Ardenghy M, et al. Diagnosing and treating congenital melanocytic nevus simulating malignant melanoma. W V Med J 1996;92:191-3.
34. Bastian BC, LeBoit PE, Pinkel D. Genomic approaches to skin cancer diagnosis. Arch Dermatol 2001;137: 1507-11.
35. Bittencourt FV, Marghoob AA, Kopf AW, et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 2000;106:736-741.
36. Kodonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol 1991;24:747-755.
37. Reyes-Mugica M, Chou P, Byrd S, et al. Nevomelanocytic proliferations in the central nervous system of children. Cancer 1993;73:227-85.
38. Rhodes AR, Melski JW. Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr 1982;100:219-24.
39. Sahin S, Levin L, Kopf A, et al. Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol 1998;39:428-33.
40. Swerdlow A, English J, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 1995;32:595-9.
41. Illig C, Weidener F, Hundeiker H, et al. Congenital nevi less than or equal to 10 cm as precursors to melanoma: 52 cases, a review, and a new conception. Arch Dermatol 1985;121:1274-81.
42. Betti R, Inselvini E, Vergani R, et al. Small congenital nevi associated with melanoma: case reports and considerations. J Dermatol 2000;27:583-90.
43. Bono A, Bartoli C, Zurrida SM, et al. Let's stop worrying about pigmented skin lesions in children. Eur J Cancer 1994;30A:417.
44. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.
45. Eaglstein W, Falanga V. Tissue engineering for skin: an update. J Am Acad Dermatol 1998;39:1007-10.
46. Cohen MA, Eaglstein WH. Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Dermatol 2001;45:857-62.
47. Koveker GB. Growth factors in clinical practice. Int J Clin Pract 2000;54:590-3.
48. Casanova D, Bardot J, Andrac-Meyer L, et al. Early curettage of giant congenital naevi in children. Br J Dermatol 1998;138:341-5.
49. Bohn J, Svensson H, Aberg M. Dermabrasion of large congenital melanocytic naevi in neonates. Scand J Plast Reconstr Surg Hand Surg 2000;34:321-6.
50. 2 laser. Br J Plast Surg 1998;51:570-1.
51. Nelson JS, Kelly KM. Q-switched laser treatment of a congenital melanocytic nevus. Dermatol Surg 1999; 25:274-6.
52. Duke D, Byers HR, Sober AJ, et al. Treatment of benign and atypical nevi with the normal-mode ruby laser and the Q-switched ruby laser: clinical improvement but failure to completely eliminate nevomelanocytes. Arch Dermatol 1999;135:290-6.
53. Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology 1998;197:71-3.
54. Giam YC, Williams ML, Leboit PE, et al. Neonatal erosions and ulcerations in giant congenital melanocytic nevi. Pediatr Dermatol 1999;16:354-8.
55. Borbujo J, Jara M, Cortes L, et al. A newborn with nodular ulcerated lesion on a giant congenital nevus. Pediatr Dermatol 2000;17:299-301.
56. Rhodes AR. Intervention strategy to prevent lethal cutaneous melanoma: use of dermatologic photography to aid surveillance of high-risk persons. J Am Acad Dermatol 1998;39:262-7.
57. Oliveria SA, Nehal KS, Marghoob AA, et al. Use of photography and dermoscopy in dermatology clinics: a survey of dermatology residency programs in the United States. Melanoma Res 2001;11:S147.
58. Bafounta M, Beauchet A, Aegerter P, et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001;137:1343-50.
59. Langley R, Rajadhyaksha M, Dwyer P, et al. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J Am Acad Dermatol 2001;45:365-76.
60. Bauer J, Metzler G, Rassner G, et al. Dermatoscopy turns histopathologist's attention to the suspicious area in melanocytic lesions. Arch Dermatol 2001;137: 1338-40.
61. Charles CA, Lee G, Marghoob AA, et al. In vivo confocal scanning laser microscopy of congenital melanocytic nevi that are suspicious for having developed malignant melanoma. Melanoma Res 2001;11:S183.
62. Busam KJ, Charles C, Lee G, et al. Morphologic features of melanocytes, pigmented keratinocytes, and melanophages by in vivo confocal scanning laser microscopy. Mod Pathol 2001;14:862-8.
63. Carli P, Massi D, Santucci M, et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol 1999; 40:549-57.
64. Yarosh D, Klein J, O'Connor A, et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study. Lancet 2001;357:926-9.
65. Salti GI, Kichina JV, DasGupta TK, et al. Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melanoma Res 2001;11:99-104.
66. Frieden IJ, Williams ML, Barkovich AJ. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol 1994;31:423-9.
67. Barkovich AJ, Frieden IJ, Williams ML. MR of neurocutaneous melanosis. AJNR Am J Neuroradiol 1994; 15:859-67.
68. Kinsler VA, Aylett SE, Coley SC, et al. Central nervous system imaging and congenital melanocytic naevi. Arch Dis Child 2001;84:152-5.
69. Foster RD, Williams ML, Barkovich AJ, et al. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 2001;107:933-41.
70. Ruiz-Maldonado R, del Rosario BM, Hidalgo-Galvan LR, et al. Giant congenital melanocytic nevi, neurocutaneous melanosis and neurological alterations. Dermatology 1997;195:125-8.
71. Gondo K, Kia R, Tokunaga Y, et al. Age-related changes of the MR appearance of CNS involvement in neurocutaneous melanosis complex. Pediatr Radiol 2000;30:866-8.
72. Yoshioka S, Miyayama H, Ishihara A, et al. Neurocutaneous melanosis: a case report. No To Shinkei 1994;46:279-84.